162 related articles for article (PubMed ID: 15019859)
1. Correlation between cardiovascular disease and diabetes mellitus: current concepts.
Nesto RW
Am J Med; 2004 Mar; 116 Suppl 5A():11S-22S. PubMed ID: 15019859
[TBL] [Abstract][Full Text] [Related]
2. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
3. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients.
Jermendy G
Acta Diabetol; 2003 Dec; 40 Suppl 2():S370-4. PubMed ID: 14704871
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
5. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
7. [Hyperglycemia and cardiovascular events].
Schneider CA; Gallwitz B; Hanefeld M; Leschke M; Müller-Wieland D; Zeymer U; Erdmann E
Dtsch Med Wochenschr; 2004 Nov; 129(47):2553-7. PubMed ID: 15543474
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and cardiovascular risk markers.
Erdmann E
Curr Med Res Opin; 2005; 21 Suppl 1():S21-8. PubMed ID: 15811196
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
10. Preventing cardiovascular events in patients with diabetes mellitus.
Abraham WT
Am J Med; 2004 Mar; 116 Suppl 5A():39S-46S. PubMed ID: 15019862
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of cardiovascular disease in people with dysglycemia.
Bianchi C; Miccoli R; Penno G; Del Prato S
Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
[TBL] [Abstract][Full Text] [Related]
12. Optimizing cardiovascular outcomes in diabetes mellitus.
Sobel BE
Am J Med; 2007 Sep; 120(9 Suppl 2):S3-11. PubMed ID: 17826044
[TBL] [Abstract][Full Text] [Related]
13. The proinflammatory and hypercoagulable state of diabetes mellitus.
Aras R; Sowers JR; Arora R
Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction and cardiovascular disease: integrative concepts and strategies.
Billups KL
Am J Cardiol; 2005 Dec; 96(12B):57M-61M. PubMed ID: 16387569
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
18. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
19. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
